AKT1 and metabolic syndrome: Pre-clinical studies have shown that dyslipidemia, in an Apolipoprotein (Apo) E knockout (ApoE−/−) mice model, promote tumor growth and metastasis development through activation of PI3K/Akt signal pathway [44] due to increased cholesterol levels.